Posts

AbbVie’s migraine medication Qulipta gets positive CHMP...

The medication could be a strong contender in the EU migraine market as a daily ...

Diabetes will be ‘a defining disease of this century’ a...

"The world has failed to understand the social nature of diabetes and underestim...

STAT+: FDA rejects Intercept’s NASH drug, prompting a p...

The FDA rejected Intercept’s investigational treatment for NASH on Thursday, der...

CMS proposes new pathway for reimbursing breakthrough d...

The new rule doesn't explicitly make getting reimbursement easier, but it will a...

STAT+: Congress explores changes to the way Medicare pa...

Lawmakers in both parties talked about overhauling a 2015 law, MACRA, that sets ...

The best AI opportunities, tech to improve 988, and an ...

In the latest edition of STAT's Health Tech newsletter: The best AI opportunitie...

Opinion: The FDA’s approval of a new gene therapy for D...

This is not the final victory for people with Duchenne muscular dystrophy. It is...

STAT+: Medicare puts out new details for covering the A...

The floodgates could open if the FDA approves Leqembi next month. Medicare just ...

Listen: Messy PBM conflicts, debatable vaccines, & the ...

Who's watching the drug price watchmen? Are RSV vaccines too expensive? And is i...

STAT+: FDA grants conditional approval to Sarepta’s gen...

The Food and Drug Administration granted conditional approval Thursday to the fi...

STAT+: The strategy behind the pharmaceutical industry’...

Legal experts unpacked the pharmaceutical industry's scattershot approach to cha...

FDA moves to stop vape shops from selling Elf Bar, Esco...

The FDA is ramping up its efforts to force vape shops and other retailers to sto...

A looming penicillin shortage threatens pregnant adults...

Without access to Bicillin, pregnant adults with syphilis and their newborns cou...

STAT+: Pharmalittle: Europe regulator raised safety sig...

The U.S. government has asked a federal judge to overturn a recent case in which...

STAT+: U.S. seeks a new trial over royalties on Gilead ...

The U.S. government asked a federal judge to overturn a recent case which found ...

A 988 operator, faced with a flood of calls, turns to A...

"Giving people the constant feedback that they need to improve is going to be th...